Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Hypnion logo — Advancing neuroscience to enhance sleep and wake-alertness w...

Hypnion

Advancing neuroscience to enhance sleep and wake-alertness with innovative treatments for CNS disorders.

Founded 2000 Series B Total: $78.00M Biotechnology, Health Care +1

General Information

Company Name Hypnion
Founded Year 2000
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Hypnion. To contact Hypnion, visit hypnion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hypnion compare?

A PDF of Hypnion and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hypnion soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hypnion

Hypnion is a neuroscience-focused firm founded in 2000 and acquired by Eli Lilly and Company. The company's slogan "Advancing neuroscience to enhance sleep and wake-alertness with innovative treatments for CNS disorders," highlights its dedication to the discovery and development of new treatments for central nervous system disorders, particularly in addressing sleep and wake-alertness issues as well as circadian rhythm abnormalities. Hypnion offers SCORE-2004, a drug discovery platform specifically designed to measure the impact of drugs on sleep and wake parameters. The company falls within the Biotechnology, Health Care, Health and Wellness industries and is headquartered in Worcester, Massachusetts. Its last investment was a $20.10M Series B investment on 19 December 2005, with participation from Jafco Ventures, MPM Capital, Advanced Technology Ventures, Flagship Pioneering, Forward Ventures, GIMV, Oxford Bioscience Partners, SR One, Mintz, Alexandria Real Estate Equities.

Business keywords: Neuroscience, Drug discovery, CNS disorders, Sleep disorders, Wake-alertness, Circadian rhythm abnormalities, Therapeutics, Eli Lilly and Company, Biopharmaceutical, Neurological treatments

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $20.10M 10
Jafco Ventures MPM Capital Advanced Technology Ventures
Jafco Ventures, MPM Capital +8
19 Dec 2005
Series B $47.50M -
17 Mar 2003
Series A $10.40M -
06 Oct 2000

Hypnion Alternatives & Competitors

View All Alternatives
Hypnion vs
BlackThorn Therapeutics
BlackThorn Therapeutics

Pioneering precision medicine for CNS disorders through advanced computational and clinical neurosci...

Series B
AI, Biotechnology
Hypnion vs
AtmosR
AtmosR

Pioneering treatments to restore autonomous breathing and safety for those with rare central nervous...

Non Equity Assistance
2-10 employees
Biotechnology, Health Care
Hypnion vs
Anthera Pharmaceuticals
Anthera Pharmaceuticals

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health

Post-IPO Equity
Biotechnology, Health Care
View all alternatives

FAQ About Hypnion

Advancing neuroscience to enhance sleep and wake-alertness with innovative treatments for CNS disorders.
Hypnion was founded in 2000.
Hypnion operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Neuroscience, Drug discovery, CNS disorders and Sleep disorders.
Hypnion has completed 3 funding rounds, raising a total of $78.00M. The latest funding stage is Series B.
Top alternatives and competitors to Hypnion include BlackThorn Therapeutics, AtmosR, Anthera Pharmaceuticals, XWPharma, Reservoir Neuroscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hypnion and BlackThorn Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hypnion, https://bouncewatch.com/company/hypnion, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout